Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses.

Rowley JW, Finn AV, French PA, Jennings LK, Bluestein D, Gross PL, Freedman JE, Steinhubl SR, Zimmerman GA, Becker RC, Dauerman HL, Smyth SS; 2011 Platelet Colloquium Participants.

Circ Cardiovasc Interv. 2012 Apr;5(2):296-304. doi: 10.1161/CIRCINTERVENTIONS.111.965426. Review. No abstract available.

PMID:
22511738
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[The cellular immunity link in children with chronic opisthorchiasis before and after chloxyl treatment].

Pomogaeva AP, Lavrova KV, Pozdeeva LP, Shurupova AV.

Med Parazitol (Mosk). 1987 Sep-Oct;(5):31-4. Russian. No abstract available.

PMID:
3437837
[PubMed - indexed for MEDLINE]
3.

Phospholipase A2: its role in ADP- and thrombin-induced platelet activation mechanisms.

Puri RN.

Int J Biochem Cell Biol. 1998 Oct;30(10):1107-22. Review.

PMID:
9785476
[PubMed - indexed for MEDLINE]
4.

Platelets and cardiovascular disease.

Willoughby S, Holmes A, Loscalzo J.

Eur J Cardiovasc Nurs. 2002 Dec;1(4):273-88. Review.

PMID:
14622657
[PubMed - indexed for MEDLINE]
5.

Platelet dysfunction in central obesity.

Anfossi G, Russo I, Trovati M.

Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):440-9. doi: 10.1016/j.numecd.2009.01.006. Epub 2009 Apr 5. Review.

PMID:
19346117
[PubMed - indexed for MEDLINE]
6.

Our expanding view of platelet functions and its clinical implications.

Ombrello C, Block RC, Morrell CN.

J Cardiovasc Transl Res. 2010 Oct;3(5):538-46. doi: 10.1007/s12265-010-9213-7. Epub 2010 Jul 27. Review.

PMID:
20661787
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Evidence strength in FDA premarket approval of cardiovascular devices.

Kong DF, Hasselblad V, Krucoff MW.

JAMA. 2010 Apr 28;303(16):1599-600; author reply 1600-1. doi: 10.1001/jama.2010.511. No abstract available.

PMID:
20424248
[PubMed - indexed for MEDLINE]
8.
9.

Influence of antidepressants on hemostasis.

Halperin D, Reber G.

Dialogues Clin Neurosci. 2007;9(1):47-59. Review.

PMID:
17506225
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Nitrosoglutathione modulation of platelet activation and nitric oxide synthase expression in promotion of flap survival after ischemia/reperfusion injury.

Kuo YR, Wang FS, Jeng SF, Huang HC, Wei FC, Yang KD.

J Surg Res. 2004 Jun 1;119(1):92-9.

PMID:
15126088
[PubMed - indexed for MEDLINE]
11.

[Effect of polypeptides isolated from the bone marrow on immunity and hemostasis].

Morozov VG, Khavinson VKh, Kuznik BI, Seryĭ SV, Budazhapova DTs.

Gematol Transfuziol. 1984 Apr;29(4):35-8. Russian. No abstract available.

PMID:
6610599
[PubMed - indexed for MEDLINE]
12.

Experimental study of biological activity of angiogen in experimental cardiovascular and hemostasis pathology.

Lychakov AV, Shevchuk MK, Savateeva TN, Kolbasov SE, Kovalenko AL.

Bull Exp Biol Med. 2002 Jan;133(1):48-50.

PMID:
12170305
[PubMed - indexed for MEDLINE]
13.

In perspective: new medical devices and improved patient outcome.

Caldwell MA.

Prog Cardiovasc Nurs. 1995 Spring;10(2):23-7.

PMID:
7651946
[PubMed - indexed for MEDLINE]
14.

Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.

Rand ML, Wang H, Pluthero FG, Stafford AR, Ni R, Vaezzadeh N, Allison AC, Kahr WH, Weitz JI, Gross PL.

J Thromb Haemost. 2012 Jun;10(6):1109-19. doi: 10.1111/j.1538-7836.2012.04716.x.

PMID:
22463102
[PubMed - indexed for MEDLINE]
15.

Cardiovascular devices for the 1990s.

Szycher M, Lee SJ.

J Biomater Appl. 1993 Jul;8(1):31-63. No abstract available.

PMID:
8345449
[PubMed - indexed for MEDLINE]
16.

Pharmacology of platelet activation-inhibitory drugs.

Rao GH, Rao AT.

Indian J Physiol Pharmacol. 1994 Apr;38(2):69-84. Review.

PMID:
8063366
[PubMed - indexed for MEDLINE]
17.

The law on cardiovascular devices: the role of the Food and Drug Administration and physicians in its implementation.

Rahimtoola SH, Rahmoeller GA.

Circulation. 1980 Nov;62(5):919-24.

PMID:
7418175
[PubMed - indexed for MEDLINE]
18.

Platelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury.

Kuo YR, Jeng SF, Wang FS, Huang HC, Wei FC, Yang KD.

J Surg Res. 2002 Sep;107(1):50-5.

PMID:
12384064
[PubMed - indexed for MEDLINE]
19.

Platelet reactivity in prolonged stress disorders--a link with cardiovascular disease?

Montoro-García S, Shantsila E, Lip GY.

Psychoneuroendocrinology. 2011 Feb;36(2):159-60. doi: 10.1016/j.psyneuen.2010.08.010. Epub 2010 Sep 28. No abstract available.

PMID:
20875929
[PubMed - indexed for MEDLINE]
20.

Acute platelet activation induced by smoking cigarettes: in vivo and ex vivo studies in humans.

Schmidt KG, Rasmussen JW, Bonnevie-Nielsen V.

Adv Exp Med Biol. 1990;273:199-209. No abstract available.

PMID:
2149625
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk